- Consumer Products
- Latest 13.46
- Currency US$
- Change -0.46
- Percent Change -3.305 %
- Volume 2,773,736
- Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Mar 10||$-0.19||May 6||$-0.11|
12 months ended Apr 19, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.